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Abstract
Background: The relationship between insight and suicidal behavior among psychotic patients is poorly studied and possibly mediated by clinical variables. 
Objectives: Our goal was to investigate clinical differences in suicidal and non-suicidal delusional disorder (DD) patients, and to evaluate the relationship 
between insight, psychotic and depressive symptoms. Methods: Cross-sectional study in 64 consecutive DD patients. For assessment, we used the Positive and 
Negative Syndrome Scale (PANSS), the Hamilton Rating Scale for Depression (HRSD-17), the Columbia Suicide Severity Rating Scale (C-SSRS), the Personal 
and Social Performance Scale (PSP), and the first three items of the SUMD scale for insight. The sample was divided according to the presence of suicide attempts. 
To investigate psychopathological associations, bivariate correlation coefficients were used. Age at onset served as covariate in subsequent analyses. Results: 
Suicidal DD patients had higher depressive symptoms and were more frequently admitted than non-suicidal patients. A logistic regression model confirmed that 
insight, depressive symptoms and age at onset were predictors of suicidal behavior. Unawareness of the effects of medication was negatively related to depres-
sive symptoms. After adjustment, depressive symptoms were weakly correlated to better insight into the effects of medication. No other statistically significant 
correlations were found. Discussion: Depressive symptoms, insight and age at onset of disease may be potential predictors of suicidal behavior in DD patients.
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Introduction
For many decades, poor insight has been considered a prevalent 
feature in patients diagnosed with chronic psychotic disorders1. 
The vast majority of scientific literature has defined insight as a 
multidimensional concept that includes awareness of a mental ill-
ness, recognition of the need for medication, awareness of the social 
consequences, and awareness of the presence of psychotic symptoms 
and the attribution of symptoms to the illness2. 
Suicide attempts before first psychiatric consultation are preva-
lent in psychotic patients and associated with depressive comorbid-
ity3,4, and insight has also been related to suicidal behavior rates5. 
Several studies have indicated that high levels of insight, or some 
aspects of insight, may increase the risk for suicidal behavior5; on 
the other hand, other authors have found no relationships between 
insight and suicidal ideation or behavior in first-episode of psychosis 
patients5,6, as well as in schizophrenia patients7.
A recent systematic review reported that the association between 
suicidal behavior or ideation and insight may be mediated by other 
clinical variables such as depressive symptoms2. On the other hand, 
the authors hightlighted that inconsistency of findings regarding 
the influence of insight on suicidal behaviour may be explained by 
some methodological problems identified in the reviewed studies. 
However, this subject has been poorly studied in delusional disorder 
(DD) patients.
The main aims of this study were to investigate clinical differences 
in suicidal and non-suicidal DD patients, and to examine the rela-
tionship between insight, psychotic and depressive symptoms, as this 
topic has been shown to be of clinical interest in delusional patients.
Methods
Study design and participants 
We carried out a cross-sectional study by including all consecu-
tive cases of DD outpatients who attended the Barcelona Clinic 
Schizophrenia Unit (Barcelona, Spain), between 2008 and 2013. All 
patients fulfilled the following inclusion criteria: (a) diagnosis of DD 
according to DSM-IV-TR criteria, (b) age over 18 years, and (c) not 
having a previous diagnosis of schizophrenia, mental retardation or 
organic psychosis. 
The present study is a part of an ongoing study on schizophrenia 
and related disorders, which was approved by the Ethics Committee 
of the Hospital Clinic (Ref. 2007/3699).
Assessment measures
The diagnosis of DD was confirmed by using the psychosis module of 
the Structured Clinical Interview for DSM-IV axis I disorder, clinical 
version (SCID-I CV), which was assessed by two senior psychiatrists 
in charge of the cases.
We used the Positive and Negative Syndrome Scale8 to assess 
positive, negative and general psychotic symptoms. Depressive 
symptoms were assessed by using the Spanish version of the 17-item 
Hamilton Rating Scale for Depression (HRSD)9, and functionality 
by the Personal and Social Performance Scale (PSP)10. Furthermore, 
the severity of suicidal ideation and number of suicide attemps 
were obtained by using the Columbia Suicide Severity Rating Scale 
(C-SSRS)11. The first three items of the Scale to Assess Unawareness 
of Mental Disorder (SUMD)12 Spanish Version, were used for assess-
ing awareness of illness, awareness of the need for medication and 
social consequences. The SUMD scale has shown a good reability and 
validity, and ranges from 1 to 5 in which higher scores are indicative 
of unawareness of the multiple components.
Mean scores of the assessment scales were considered outcome 
variables, and sociodemographic and other clinical data served as 
secondary outcomes. The sample was divided into two groups ac-
cording to the presence or absence of suicidal attempts at lifetime.
Statistical analysis
All data were analyzed by using SPSS for Windows (Version 19.9; 
SPSS Inc., Chicago, Illinois, USA). Univariate differences in so-
ciodemographic and clinical characteristics, and assessment scales 
between patients who attempted suicide and those who were not at-
tempters were tested by using Mann-Whitney U test, χ2 and Fisher’s 
exact tests, as the distribution of data were non-parametric. A logistic 
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regression analysis was conducted to identify potential predictors 
of suicidal behavior in DD patients using depressive symptoms 
(HRSD-17), age at onset of DD, social network, and SUMD total 
scores. The relationship between the three first items of the SUMD 
scale and insight total scores, psychopathological symptoms and 
functionality were investigated using the Spearman correlation 
coefficients. In this analysis, the original sample was not divided. 
In a second step, partial correlation coefficients were applied with 
age at onset of DD as confounding variable. Significance level was 
set at 0.05 (two-tailed).
Results
Sociodemographic and clinical features in suicidal and 
non-suicidal DD patients
Of the 64 DD patients included in the study, 10 (15.6%) had attempted 
suicide at lifetime. No statistically significant differences were found 
with regard to sociodemographic variables between DD patients who 
attempted suicide and those who did not attempt. 
Suicidal DD patients showed higher rates of depressive co-
morbidity (p = 0.025), were more likely to receive antidepressants 
(p = 0.011) and were more frequently admitted to a psychiatric ward 
(p = 0.026) than non-suicidal patients.
Regarding insight and psychopathological symptoms, suicide 
attempters showed higher depressive symptoms measured by the 
HRSD-17 scale (p = 0.011), higher severity of suicidal ideation (p < 
0.001) and less awareness of social consequences with higher scores 
of the SUMD scale item 3 (p = 0.022).
A logistic regression analysis was conducted to predict suicidal 
behavior using potential confounders as predictors. The Wald cri-
terion demonstrated that insight (p = 0.048), depressive symptoms 
(0.004) and age at onset of disease (p = 0.038) made a signiﬁcant 
contribution to prediction. Social support as measured by total 
number of cohabiters was not a signiﬁcant predictor of suicidal 
behavior (Table 1).
Table 1. Demographic and clinical data, and assessment scales by clinical groups
Variables Total sample n = 64 No suicide attempters n = 54 Suicide attempters n = 10 Statistic
Sociodemographic measures
Age, mean (SD) 55.02 (12.78) 54.85 (13.49) 55.90 (8.33) U (63) = 254, Z = -0.269, p = 0.767
Marital status [n(%)] χ² = 0.598, df = 2, p = 0.742
Single 23 (35.9) 20 (37.04) 3 (30)
Married/living together 16 (25) 14 (25.93) 2 (20)
Separated/divorced/widowed 25 (39.1) 20 (37.1) 5 (50)
Educational level, years [n(%)] χ² = 0.238, df = 3, p = 0.971
< 8 7 (11) 6 (11.11) 1 (10)
8-9 16 (25) 14 (25.93) 2 (20)
10-11 22 (34.4) 18 (33.33) 4 (40)
12 or > 19 (29.6) 16 (29.63) 3 (30)
Employment status [n(%)] χ² = 1.392, df = 2, p = 0.707
Unemployed 4 (6.25) 4 (7.4) 0 (0)
Employed 21(32.81) 18 (33.33) 3 (30)
Economic benefit 39 (60.94) 32 (59.26) 7 (70)
Clinical measures
Age at onset of DD, mean (SD) 48.83 (12.61) 47.87 (13.07) 54 (8.5) U (63) = 192, Z = -1.44, p = 0.149
Accumulated years of disease, mean (SD) 12.25 (11.64) 12.78 (12.13) 9.4 (8.4) U (63) = 241, Z = -0.538, p = 0.591
DD type [n(%)] χ² = 2.735, df = 4, p = 0.603 
Persecutory 52 (81.25) 42 (77.78) 10 (100)
Erotomanic 5 (7.81) 5 (9.26) 0 (0)
Jealous 3 (4.69) 3 (5.56) 0 (0)
Grandiose 2 (3.13) 2 (3.71) 0 (0)
Somatic 2 (3.13) 2 (3.71) 0 (0)
Depressive comorbidity, [n(%)] 22 (34.4) 15 (27.78) 7 (70) p = 0.025*; FET
Antidepressant use, [n(%)] 26 (40.63) 18 (33.33) 8 (80) p = 0.011*; FET
Lifetime admissions, mean (SD) 1.02 (1.13) 0.89 (1.09) 1.7 (1.16) U (63) = 156.5, Z = -2.22, p = 0.026*
Number of suicide attemps, mean (SD) 0.23 (0.66) 0 (0) 1.5 (0.972) U (63) = 0.0, Z = -7.913, p = 0.000*
Assessment scales, mean (SD)
PANSS total scale 83.83 (18.46) 84.04 (17.58) 82.70 (23.74) U (63) = 247, Z = -0.060, p = 0.952
PANSS positive subscale 22.59 (5.83) 23.04 (5.85) 20.2 (5.33) U (63) = 190.5, Z = -1.472, p = 0.141
PANSS negative subscale 18.17 (5.71) 18.07 (5.67) 18.70 (6.26) U (63) = 251.5, Z = -0.343, p = 0.732
PANSS general subscale 43.06 (9.2) 42.93 (8.41) 43.8 (13.24) U (63) = 244, Z = -0.481, p = 0.630
SUMD scale 14.19 (1.47) 14.11 (1.54) 14.60 (0.97) U (63) = 215, Z = -1.176, p = 0.239
SUMD, awareness illness 4.81 (0.56) 4.81 (0.55) 4.80 (0.63) U (63) = 268, Z = -0.068, p = 0.946
SUMD, awareness effects of medication 4.73 (0.57) 4.72 (0.6) 4.80 (0.42) U (63) = 265, Z = -0.132, p = 0.895
SUMD, awareness social consequences 4.64 (0.574) 4.57 (0.60) 5 (0) U (63) = 170, Z = -2.282, p = 0.022*
PSP score 52.64 (15.26) 52.26 (15.91) 54.70 (11.55) U (63) = 258, Z = -1.36, p = 0.174
HRSD-17 score 10.48 (6.21) 9.54 (5.62) 15.60 (7.03) U (63) = 132.5, Z = -2.552, p = 0.011*
Suicidal ideation severity (C-SSRS) 3.97 (7.31) 1.94 (4.92) 14.90 (8.62) U (63) = 72.5, Z = -4.803, p = 0.000*
* P < 0.05.
C-SSRS: Columbia Suicide Severity Rating Scale; DD: delusional disorder; df: degrees of freedom; FET: Fisher’s Exact Test; HRSD: Hamilton Rating Scale for Depression; p: p-value; PANSS: Positive 
and Negative Syndrome Scale; PSP: Personal and Social Performance Scale; SD: Standard deviation; SUMD: total for items 1, 2 and 3; U: Mann-Whitney U test; χ²: Chi-square test. 
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Correlational analysis between insight and 
psychopathological symptoms
SUMD total score was negatively associated with the age at the study 
inclusion (r = 0.335, p = 0.007) and age at onset of DD (r = -0.375, 
p = 0.002). 
Prior to the correction by potential confounding factors, al-
though no statistical significance was reached, total insight showed 
a tendency toward a positively correlation with accumulated years 
of disease (r = 0.227, p = 0.072) and was negatively related to PANSS 
general subscale scores (r = -0.225, p = 0.073). SUMD total scores 
were not related to positive and negative symptoms, functionality, 
depressive symptoms or severity of suicidal ideation, as measured by 
the C-SSRS scale. Unawareness of disease and of the effects of medica-
tion showed a tendency to be negatively associated with depressive 
symptoms (r = -0.215, p = 0.088; r = -0.235, p = 0.062). Unawareness 
of the social consequences was negatively associated with PANSS 
total scale (r = -0.266, p = 0.034), PANSS general subscale (r = -0.258, 
p = 0.040), current age (r = -0.344, p = 0.005) and age at onset of 
DD (r = -0.368, p = 0.003), and positively associated with number of 
suicide attempts (r = 0.287, p = 0.022). A tendency toward positively 
correlation was shown between unawareness of social consequences 
and functionality (r = 0.235, p = 0.061).
In a second step, age at onset of DD was included into the 
correlational analysis as confounding variable. After adjustment, 
unawareness of the effects of medication was negatively related to 
depressive symptoms (r = -0.264, p = 0.037). Other correlations were 
no longer statistically significant.
Discussion
In our sample, suicidal delusional disorder (DD) patients had higher 
depressive symptoms and were more frequently admitted to a psychi-
atric ward than non-suicidal patients. These findings are consistent 
with a previous study carried out by our team4. In the aforementioned 
study we found that DD patients with depressive comorbidity (DC) 
had higher rates of suicidal behavior and suicidal ideation than pa-
tients without DC. Thus, based on our findings, it is not possible to 
exclude a relationship between insight and suicidal behavior in DD 
patients, as suggested by some authors7.
In the present study, after conducting regression models, depres-
sive symptoms, insight and age at onset of disease were confirmed to 
be clinical predictors of suicidal behavior in DD patients. Further, 
this is in agreement with a recent systematic review carried by López-
Moríñigo and coworkers2, who concluded that if any relationship 
exists between insight and suicidal behavior in psychotic patients, it 
may be related to other clinical variables, such as depressive symptoms. 
In a further step, we carried out a correlation analysis between 
total insight scores, the first three items of the SUMD scale, and 
psychopathological symptoms. When uncorrected for potential 
confounders, DD patients with high clinical insight in terms of 
awareness of disease and recognition of the effects of medication had 
significantly higher depression scores and greater histories of suicide 
attempts compared to patients with low clinical insight. Although 
statistical significance was not reached, these findings are in agree-
ment with the systematic review mentioned above2. Furthermore, 
patients with better awareness of the social consequences had a later 
age at onset of DD.
In a second step, we included age at onset of DD into the cor-
relational analysis as confounding variable, as it was significantly 
correlated with insight scores in the non-controlled correlation 
analysis. When adjusted, DD patients with higher depressive symp-
toms showed better insight into the effects of medication, which was 
probably mediated by age at onset of DD. In our point of view, it is 
reasonable that patients with an earlier psychotic diagnosis would 
show lower insight levels than patients with a later age at onset. 
To the best of our knowledge, this is the first study to specifically 
investigate sociodemographic and clinical differences in two clinical 
subgroups of DD patients, those who have attempted suicide at lifetime 
and those who did not attempt it. Furthermore, the main strength of 
our study is that it is the first to specifically investigate clinical correla-
tions between insight, depressive and psychotic symptoms, and number 
of previous suicide attempts, specifically in a sample formed by DD 
patients. Some limitations in our study should be taken into account. 
Our study has a cross-sectional design and the sample size is small. 
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